-
Rizzello F, Viciani E, Gionchetti P, Filippone E, Imbesi V, Melotti L, Dussias NK, Salice M, Santacroce B, Padella A, Velichevskaya A, Marcante A, Castagnetti A. Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients. Frontiers in Cellular and Infection Microbiology. 2024. doi: 10.3389/fcimb.2024.1352202
-
Rizzello F., Saracino IM, Gionchetti P, Valerii MC, Ricci C, Imbesi V, Filippone E, Bellocchio I, Dussias NK, Dervieux T, Spisni E. Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches. Nutrients. 2024. doi: 10.3390/nu16020280
-
Saracino IM, Spisni E, Imbesi V, Ricci C, Dussias NK, Alvisi P, Gionchetti P, Rizzello F, Valerii MC. The Bidirectional Link between Nutritional Factors and Inflammatory Bowel Diseases: Dietary Deficits, Habits, and Recommended Interventions-A Narrative Review. Foods. 2023 May 14;12(10):1987. doi: 10.3390/foods12101987. PMID: 37238805; PMCID: PMC10217076.
- Rizzello F, Gionchetti P, Spisni E, Saracino IM, Bellocchio I, Spigarelli R, Collini N, Imbesi V, Dervieux T, Alvisi P, Valerii MC. Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients. Int J Mol Sci. 2023 Jan 12;24(2):1494. doi: 10.3390/ijms24021494. PMID: 36675009; PMCID: PMC9865585.
- Spisni E, Turroni S, Alvisi P, Spigarelli R, Azzinnari D, Ayala D, Imbesi V, Valerii MC. Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions. Front Pharmacol. 2022 Mar 18;13:841782. doi: 10.3389/fphar.2022.841782. PMID: 35370685; PMCID: PMC8971809.
